Antimicrobial Susceptibility Testing in a Rapid Single Test via an Egg-like Multivolume Microchamber-Based...

Area of Science:

• Microfluidics
• Antimicrobial Susceptibility Testing
• Diagnostic Technology

Background:

• Rapid determination of antimicrobial effectiveness is crucial for treating bacterial infections.
• Conventional methods for antimicrobial susceptibility testing can be time-consuming.
• There is a need for faster, more precise diagnostic tools in clinical settings.

Purpose of the Study:

• To develop and validate a novel microfluidic platform for rapid antimicrobial susceptibility testing.
• To create a system capable of generating a gradient of antibiotic concentrations quickly.
• To assess the precision and efficiency of the new platform compared to existing methods.

Main Methods:

• Development of an egg-like multivolume microchamber-based microfluidic (EL-MVM2) platform.
• Utilizing diffusion to create a gradient of antibiotic concentrations across microchambers of varying volumes (12.56–153.86 nL).
• Validation through computational fluid dynamics simulations and experimental testing with various antibiotic drugs.

Main Results:

• The EL-MVM2 platform can generate antibiotic concentration gradients in approximately 10 minutes.
• The platform demonstrated high precision in predicting susceptibility/resistance outcomes (>97%), exceeding FDA criteria.
• The diffusion pattern was accurately modeled and experimentally confirmed.

Conclusions:

• The EL-MVM2 platform provides a fast, precise, and effective method for antimicrobial susceptibility testing.
• This technology represents a significant advancement over conventional methods for clinical diagnostics.
• The platform is suitable for point-of-care settings, improving patient outcomes and infection control.